virus-like particle adjuvant (Institut Curie)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namevirus-like particle adjuvant (Institut Curie)
Drug Alias NameHIV-2 capsid derived adjuvant (Institut Curie)
ClassificationBiologics
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsVaccination
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInstitut Curie
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitut Curie
Active IndicationsN/A
Inactive IndicationsVaccination

Other Information

ATC CodeN/A
Related LinksN/A